Once-daily, modified-release hydrocortisone in patients with adrenal insufficiency - Authors' reply

Diffusion-weighted magnetic resonance imaging as a promising technique for detection and follow-up of liver metastases from neuroendocrine tumors: a retrospective and prospective study from the NETTARE task force.

Journal of endocrinological investigation·2026

Primary functional hypothalamic amenorrhoea in the context of feeding and eating disorders or excessive exercise: Insights from non-athletic and elite athletic populations.

Journal of neuroendocrinology·2026

Muscle quality is associated with health-related quality of life in patients with eating disorders.

Clinical nutrition ESPEN·2026

Real-World Effectiveness and Safety of Osilodrostat in Cushing's Syndrome: A Retrospective Phase IV Study.

The Journal of clinical endocrinology and metabolism·2026

Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study.

The lancet. Diabetes & endocrinology·2026

Molecular Dynamics Analysis of the Stereoselective Recognition of Myo-Inositol and D-Chiro-Inositol in a Protein-Based Biosensor.

Sensors (Basel, Switzerland)·2026

Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case-control study.

The lancet. Diabetes & endocrinology·2026

From adiposity to multisystem morbidity: the case for weight loss as disease modification.

The lancet. Diabetes & endocrinology·2026

Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial.

The lancet. Diabetes & endocrinology·2026

Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial.

The lancet. Diabetes & endocrinology·2026

Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial.

The lancet. Diabetes & endocrinology·2026

Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial.

The lancet. Diabetes & endocrinology·2026

First Report on the Phytochemical and Pharmacological Properties of Hedysarum yilmazunalii.

Chemistry & biodiversity·2026

Pharmacognostic profiling of Bridelia ovata leaves and evaluation of signal transducer and activator of transcription 3-mediated antiproliferative effects in triple-negative breast cancer.

Journal of advanced pharmaceutical technology & research·2026

Molecular mechanisms of traditional Chinese medicine in skin aging: a narrative review.

Frontiers in pharmacology·2026

Metyrapone in the Management of Severe Hypercortisolism Secondary to Ectopic Cushing's Syndrome.

Case reports in endocrinology·2026

Simvastatin as an immunomodulator and anti-myeloma agent - epidemiological, in vitro and murine model studies.

Frontiers in immunology·2026

The Silent Valve Culprit: A Case Report and Literature Review of Isolated Cabergoline-Induced Mitral Regurgitation.

Cureus·2026

Related Experiment Videos

Once-daily, modified-release hydrocortisone in patients with adrenal insufficiency - Authors' reply

Related Concept Videos

Diffusion-weighted magnetic resonance imaging as a promising technique for detection and follow-up of liver metastases from neuroendocrine tumors: a retrospective and prospective study from the NETTARE task force.

Primary functional hypothalamic amenorrhoea in the context of feeding and eating disorders or excessive exercise: Insights from non-athletic and elite athletic populations.

Muscle quality is associated with health-related quality of life in patients with eating disorders.

Real-World Effectiveness and Safety of Osilodrostat in Cushing's Syndrome: A Retrospective Phase IV Study.

Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study.

Molecular Dynamics Analysis of the Stereoselective Recognition of Myo-Inositol and D-Chiro-Inositol in a Protein-Based Biosensor.

Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case-control study.

From adiposity to multisystem morbidity: the case for weight loss as disease modification.

Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial.

Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial.

Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial.

Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial.

First Report on the Phytochemical and Pharmacological Properties of Hedysarum yilmazunalii.

Pharmacognostic profiling of Bridelia ovata leaves and evaluation of signal transducer and activator of transcription 3-mediated antiproliferative effects in triple-negative breast cancer.

Molecular mechanisms of traditional Chinese medicine in skin aging: a narrative review.

Metyrapone in the Management of Severe Hypercortisolism Secondary to Ectopic Cushing's Syndrome.

Simvastatin as an immunomodulator and anti-myeloma agent - epidemiological, in vitro and murine model studies.

The Silent Valve Culprit: A Case Report and Literature Review of Isolated Cabergoline-Induced Mitral Regurgitation.

Related Experiment Videos

Once-daily, modified-release hydrocortisone in patients with adrenal insufficiency - Authors' reply

Related Concept Videos

Related Articles